Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant.
about
Phosphatidylinositol 3-monophosphate is involved in toxoplasma apicoplast biogenesisSynergistic effect of clindamycin and atovaquone in acute murine toxoplasmosisGrowth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylaseActivity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondiiCharacterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiologySelective inhibition of apicoplast tryptophanyl-tRNA synthetase causes delayed death in Plasmodium falciparumPenetration of clindamycin and its metabolite N-demethylclindamycin into cerebrospinal fluid following intravenous infusion of clindamycin phosphate in patients with AIDS.Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycinLocalization of azithromycin in Toxoplasma gondii-infected cellsToxoplasma gondii: 25 years and 25 major advances for the fieldInhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.Feline ocular toxoplasmosis.Subcellular localization of acetyl-CoA carboxylase in the apicomplexan parasite Toxoplasma gondiiChemistry and biology of macrolide antiparasitic agents.In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondiiParadoxical effect of clindamycin in experimental, acute toxoplasmosis in cats.Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitroA Toxoplasma gondii mutant highlights the importance of translational regulation in the apicoplast during animal infection.Autophagy-Related Protein ATG8 Has a Noncanonical Function for Apicoplast Inheritance in Toxoplasma gondiiApoptosis-like cell death pathways in the unicellular parasite Toxoplasma gondii following treatment with apoptosis inducers and chemotherapeutic agents: a proof-of-concept studyArtemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycleDevelopment of forward genetics in Toxoplasma gondii.Drugs in development for toxoplasmosis: advances, challenges, and current status.Lower respiratory tract infections in cats: reaching beyond empirical therapy.Medicinal potential of ciprofloxacin and its derivatives.Anti-Toxoplasma activity and impact evaluation of lyophilization, hot molding process, and gamma-irradiation techniques on CLH-PLGA intravitreal implants.The efficacy of herbal medicines against Toxoplasma gondii during the last 3 decades: a systematic review.A plastid segregation defect in the protozoan parasite Toxoplasma gondii.Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.Identification of potential apicoplast associated therapeutic targets in human and animal pathogen Toxoplasma gondii ME49.Toxoplasma gondii Rab5 enhances cholesterol acquisition from host cells.An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii.A plastid organelle as a drug target in apicomplexan parasites.Targeted Phenotypic Screening in Plasmodium falciparum and Toxoplasma gondii Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules.Drug Resistance in
P2860
Q27312274-BCEBFD52-2D38-438E-91DF-3DF001A9A0A0Q28343549-2C2951FC-BCBD-4636-A461-AFE5A2E3E212Q28343700-A7D838ED-A9BA-4234-A0D1-CDD3A02DEE2FQ28369142-4D9C286F-F828-47C3-AACA-743DD9F5CBA1Q28379120-25BB24EA-41FE-4924-AF78-EC4181CDF81EQ30043256-A8B68AEE-328D-4D7D-A0A9-C4B5852D2EF6Q33702049-ECEB1EEB-C027-4CD8-813C-A1449F847035Q33746997-60E39870-9FBD-46F9-B721-B336BCF929A8Q33755229-E977B150-0ACE-4B58-B41C-182F90398D2EQ33956789-A0F2BC23-459D-45A3-99A2-6C10EC85C7BEQ34196036-7F70E8EA-C65C-4535-B044-26DE6A2308DFQ34276691-31A12DA2-D9D4-4752-BF74-90327D867851Q34488213-8F7EB0C7-67E4-4648-A0B5-7E02DD0DED81Q34904340-AEB2D644-17BC-47DE-821B-83D45CF30C85Q35116242-2F647840-A61D-47CE-A64F-BA1EBBCA0FF1Q35124789-0221311D-841B-4392-8127-DF91AF514734Q35137900-911E4C90-A005-4830-A60E-AF883ED357D3Q35142236-C1350256-81AD-474D-824E-2F97E1C0A471Q36227292-288415B0-291F-4EEF-AD51-99A4BF30FE68Q36791777-DC9A73E3-076B-4DE5-A9FA-7DA1BFCFA4C6Q37090661-A9E13F51-F4A1-4F25-9DDD-15D899C25833Q37250412-C5CFF679-26BD-48A3-B8B8-D974868300DCQ37613765-5FA2B3D7-3F9F-46CD-BDBA-288A0284AF0BQ37868313-6F5FDE4F-E892-4ABB-B3CD-82265288E950Q38068970-55423924-403F-4FD7-A4F2-4816B791B091Q38811119-601BE666-A13C-4C3B-95FF-3B5AE9B93059Q38937807-7528413C-C74B-4352-B293-923BC318304BQ39673553-1EC5DF37-14EB-4D9E-9627-9C883062DFC9Q39883651-855C0D54-8305-4533-8E9D-9A40FCA442F9Q41158389-47ED12F3-BA2C-4897-80CA-7973560268C0Q43925146-DC391E5F-DDAE-4C57-9847-07A8500D0ACEQ43936787-5703E59D-4184-4551-AD70-3D1C47E76E32Q47823727-51C39AD0-13D2-4121-B89C-D8BFEFA0927EQ48022900-376CC491-BF6B-4354-8FA6-B95FE3DCAB86Q58699076-60D3764D-5D56-46F5-A1CE-EA698E20E68E
P2860
Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Parasiticidal effect of clinda ...... on of a drug-resistant mutant.
@ast
Parasiticidal effect of clinda ...... on of a drug-resistant mutant.
@en
type
label
Parasiticidal effect of clinda ...... on of a drug-resistant mutant.
@ast
Parasiticidal effect of clinda ...... on of a drug-resistant mutant.
@en
prefLabel
Parasiticidal effect of clinda ...... on of a drug-resistant mutant.
@ast
Parasiticidal effect of clinda ...... on of a drug-resistant mutant.
@en
P2093
P2860
P356
P1476
Parasiticidal effect of clinda ...... on of a drug-resistant mutant.
@en
P2093
E R Pfefferkorn
R F Nothnagel
S E Borotz
P2860
P304
P356
10.1128/AAC.36.5.1091
P407
P577
1992-05-01T00:00:00Z